Compliance Rate
Compliance Rate
20.0%
Compliant submissions
2
Incompliant submissions
8
Total trials
10
My Organizations' Clinical Trials
Showing 1375 of 1573 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/18/13
End: 04/30/17
Due: 04/30/18
Phase: N/A
Priority: Normal
Start: 11/17/21
End: 08/08/22
Due: 08/08/23
Phase: N/A
Priority: Normal
Start: 02/28/13
End: 04/30/13
Due: 04/30/14
Phase: N/A
Priority: Normal
Start: 10/11/18
End: 02/28/21
Due: 02/28/22
Phase: N/A
Priority: Normal
Start: 08/18/17
End: 08/10/18
Due: 08/10/19
Phase: N/A
Priority: Normal
Start: 06/30/15
End: 03/10/20
Due: 03/10/21
Phase: N/A
Priority: Normal
Start: 02/01/18
End: 01/31/26
Due: 01/31/27
Phase: N/A
Priority: Normal
Start: 08/31/05
End: 03/31/08
Due: 03/31/09
Phase: N/A
Priority: Normal
Start: 02/01/25
End: 01/31/28
Due: 01/31/29
Phase: N/A
Priority: Normal
Start: 06/22/21
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 04/05/22
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 10/20/22
End: 07/31/26
Due: 07/31/27
Phase: N/A
Priority: Normal
Start: 10/11/21
End: 05/01/27
Due: 05/01/28
Phase: N/A
Priority: Normal
Start: 02/23/24
End: 02/23/44
Due: 02/23/45
Phase: N/A
Priority: Normal
Start: 04/30/06
End: 01/31/08
Due: 01/31/09
Phase: N/A
Priority: Normal
Start: 10/31/16
End: 11/30/19
Due: 11/30/20
Phase: N/A
Priority: Normal
Start: 08/31/15
End: 04/30/17
Due: 04/30/18
Phase: N/A
Priority: Normal
Start: 02/29/16
End: 05/31/16
Due: 05/31/17
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 08/31/25
Due: 08/31/26
Phase: N/A
Priority: Normal
Start: 12/31/13
End: 06/30/15
Due: 06/30/16
Phase: N/A
Priority: Normal
Start: 02/11/25
End: 08/31/26
Due: 08/31/27
Pharmacokinetic Characteristics and Anti-Inflammatory Effects of Aprepitant In HIV-Infected Subjects
Phase: N/A
Priority: Normal
Start: 05/31/14
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 11/30/17
Due: 11/30/18
Phase: N/A
Priority: Normal
Start: 01/20/21
End: 01/01/24
Due: 01/01/25
Phase: N/A
Priority: Normal
Start: 09/29/22
End: 05/31/25
Due: 05/31/26